Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$27.54 USD
-0.45 (-1.61%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $27.54 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | 0.94 |
EPS Last Quarter | 0.96 |
Last EPS Surprise | 1.05% |
ABR | 1.42 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 4.04 |
Next Year | 4.36 |
EPS (TTM) | 3.88 |
P/E (F1) | 6.83 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 710.07M | 709.73M | 2.74B | 2.93B |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 715.00M | 720.19M | 2.75B | 2.98B |
Low Estimate | 705.14M | 699.27M | 2.74B | 2.89B |
Year ago Sales | 637.00M | 736.00M | 3.05B | 2.74B |
Year over Year Growth Est. | 11.47% | -3.57% | -9.98% | 6.79% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.94 | 1.11 | 4.04 | 4.36 |
# of Estimates | 3 | 2 | 4 | 4 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.96 | 1.12 | 4.13 | 4.70 |
Low Estimate | 0.91 | 1.10 | 3.94 | 4.15 |
Year ago EPS | 0.79 | 1.15 | 4.49 | 4.04 |
Year over Year Growth Est. | 18.99% | -3.48% | -10.02% | 7.98% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.94 | 1.11 | 4.04 | 4.36 |
7 Days Ago | 0.94 | 1.11 | 4.04 | 4.36 |
30 Days Ago | 0.94 | 1.11 | 4.04 | 4.36 |
60 Days Ago | 0.91 | 1.08 | 4.01 | 4.36 |
90 Days Ago | 0.90 | 1.07 | 4.03 | 4.38 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.94 | 1.11 | 4.04 | 4.36 |
Zacks Consensus Estimate | 0.94 | 1.11 | 4.04 | 4.36 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.96 | 0.98 | 1.15 | 0.79 | NA |
Estimate | 0.95 | 0.96 | 1.03 | 0.81 | NA |
Difference | 0.01 | 0.02 | 0.12 | -0.02 | 0.03 |
Surprise | 1.05% | 2.08% | 11.65% | -2.47% | 3.08% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more